Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-05 @ 6:00 PM
Study NCT ID:
NCT04577404
Status:
COMPLETED
Last Update Posted:
2025-09-08
First Post:
2020-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Tanabe Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MT-1186-A03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None